Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

By afschroeder • July 17, 2025

Leiva O, Liu O, Kanelidis A, Swat S, Gozdecki L, Belkin M, Grinstein J, Kalantari S, Kim G, DeCara J, Chung B, Patel A, Odenike O, Yang EH, Bloom M, Alvarez-Cardona J, How J, Hobbs G. Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Jul 3:S2666-0873(25)00237-6. doi: 10.1016/j.jaccao.2025.05.010. Epub ahead of print. PMID: 40668166.

Tags: bidirectional cardio-oncology, Cardiology/Epi, cardiomyopathy, heart failure, leukemia, myelofibrosis, myeloproliferative neoplasms, Publications, pulmonary hypertension

Related Posts

Access to digital health technologies: personalized framework and global perspectives

Narayan SM, Chung MK, Adedinsewo D, Brant LCC, Davis LL, Duncker D, Hall JL, Han JK, Lam CSP, Lewis E, Loscalzo J, Márquez MF, Rahimzadeh[...]

Detecting structural heart disease from electrocardiograms using AI

Poterucha TJ, Jing L, Ricart RP, Adjei-Mosi M, Finer J, Hartzel D, Kelsey C, Long A, Rocha D, Ruhl JA, vanMaanen D, Probst MA, Daniels[...]

Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study

Nguyen KT, Yu J, Hedlin H, Phillips AT, Desai S, Cheung L, Kowey PR, Jain SS, Rumsfeld JS, Russo AM, Granger CB, Hills MT, Desai[...]